GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹584 Cr | ₹557 Cr | ₹612 Cr | ₹699 Cr | ₹812 Cr |
What is the latest Total Non-Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹584 Cr |
| Mar2025 | ₹557 Cr |
| Mar2024 | ₹612 Cr |
| Mar2023 | ₹699 Cr |
| Mar2022 | ₹812 Cr |
How is Total Non-Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹584 Cr | 4.76 | |
| Mar2025 | ₹557 Cr | -8.92 | |
| Mar2024 | ₹612 Cr | -12.43 | |
| Mar2023 | ₹699 Cr | -13.95 | |
| Mar2022 | ₹812 Cr | - | |
Compare Total Non-Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,222.2 Cr | 5.1% | 5.1% | 4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 5.1% |
5.1% |
4.5% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses